Viewing Study NCT01537861


Ignite Creation Date: 2025-12-24 @ 11:54 AM
Ignite Modification Date: 2025-12-31 @ 9:38 PM
Study NCT ID: NCT01537861
Status: TERMINATED
Last Update Posted: 2015-01-26
First Post: 2012-02-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
Sponsor: Washington University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module